NASDAQ:GILD
Gilead Sciences, Inc (GILD) receives a Buy rating from Truist
Gilead Sciences, Inc’s recent filing unveils that its Director Bluestone Jeffrey unloaded Company’s shares for reported $0.63 million on Nov ...
Gilead Sciences, Inc (GILD) gets rating Resumed from Truist
Gilead Sciences, Inc’s filing revealed that its Chief Financial Officer Dickinson Andrew D unloaded Company’s shares for reported $0.31 million ...
Keeping an Eye on Gilead Sciences, Inc (GILD) After Insider Trading Activity
Gilead Sciences, Inc’s recent filing unveils that its Officer JOHANNA MERCIER acquired Company’s shares for reported $3.52 million on Nov ...
Gilead Sciences, Inc (GILD) may enjoy gains as insiders got busy in the recent days
Gilead Sciences, Inc’s recent filing unveils that its Chairman & CEO O’Day Daniel Patrick unloaded Company’s shares for reported $1.19 ...
Daiwa Securities gives an Outperform recommendation for Gilead Sciences, Inc (GILD)
Gilead Sciences, Inc’s recently made public that its Chairman & CEO O’Day Daniel Patrick unloaded Company’s shares for reported $1.19 ...
GILD price target predicted to rise nearly 135 in 12 months
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Gilead Sciences, ...
